Drawing for SPECIALTY IG FOR NEUROMUSCULAR (SIGN)

USPTO serial 88203048

SPECIALTY IG FOR NEUROMUSCULAR (SIGN)

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SINGH, TEJBIR
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SPECIALTY IG FOR NEUROMUSCULAR (SIGN)?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arkadia Olson

Arkadia Olson Express Scripts Strategic Development, Inc.One Express Way, HQ1St. Louis, MO 63121UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
036Providing prior authorization and other support services for healthcare providers that prescribe intravenous medications and other medications for chronic and rare conditions; financial and insurance assistance supportACTIVE—
041Providing patient and prescriber educational services, namely, conducting programs in the field of chronic diseases and rare conditions and specialty medications, and distributing course materials in connection therewith; conducting programs in the field of proper product-reconstitution and administration; providing resources appropriate for support of disease management; educational services in the field of infusion and injection therapy for physicians and patients, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, namely, classes, one on one sessions and telephonic workshops which provide physicians and patients with specific characteristics associated with disease management productsACTIVE—
044Care specializing in the treatment, prevention and control of chronic diseases, and related to specialty medications; support services for the treatment, and control of chronic and rare conditions; administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of chronic and rare conditions; administration of pharmaceutical preparations used in the treatment of chronic diseases and rare conditions; providing information concerning medical care and treatment; disease management services; telephone hotline counseling, namely, offering healthcare advice; services consisting of providing guidance and consultation to chronically ill patients; pharmacy support services, namely, specialized pharmaceutical advice, pump program, patient support programs, educational materials in the field of infusion and injection therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 13, 2019MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 13, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 4, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 4, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 15, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 15, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 15, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 11, 2019DOCKASSIGNED TO EXAMINER—
Dec 11, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 24, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance